Gastric electrical stimulation (GES) has been suggested as a potential therapy for patients with obesity or gastric motility disorders. The aim of this study was to investigate the spinal mechanism of GES effects on gastric functions. Extracellular potentials of single spinal (T9-T10) neurons were recorded in pentobarbital anesthetized, paralyzed, ventilated male rats (n = 19). Gastric distension (GD) was produced by air inflation of a balloon. One pair of platinum electrodes (1.0-1.5 cm apart) was sutured onto the serosal surface of the lesser curvature of the stomach. GES with four sets of parameters was applied for 1 min: GES-A (6 mA, 0.3 ms, 40 Hz, 2 s on, 3 s off), GES-B (6 mA, 0.3 ms, 14 Hz, 0.1 s on, 5 s off), GES-C (6 mA, 3 ms, 40 Hz, 2 s on, 3 s off), GES-D (6 mA, 200 ms, 12 pulses/min). 62/158 (39%) spinal neurons responded to GD (20, 40, 60 mmHg, 20 s. Most GD-responsive neurons (n = 43) had excitatory responses; the remainder had inhibitory (n = 12) or biphasic responses (n = 7). GES-A, -B, -C and -D affected activity of 12/33 (36%), 4/31 (13%), 22/29 (76%) and 13/30 (43%) GD-responsive neurons, respectively. Bilateral cervical vagotomy did not significantly alter mean excitatory neuronal responses to GD (n = 5) or GES (n = 6). Resiniferatoxin (2.0 mg/kg, i.v.), an ultrapotent agonist of vanilloid receptor-1, abolished excitatory responses to GD and GES in 4/4 neurons recorded in vagotomized rats. The results suggested that GES mainly had an excitatory effect on T9-T10 spinal neurons with gastric inputs; neuronal responses to GES were strengthened with stimulation at an increased pulse width and/or number of pulses. The modulatory effect of GES involved thoracic spinal (sympathetic) afferent fibers containing vanilloid receptor-1. #
Introduction
Basic and clinical investigations show that gastric electrical stimulation (GES) may be a suitable treatment for some gastric motility disorders and morbid obesity (Abell and Minocha, 2002; D'Argent, 2002; Greenstein and Belachew, 2002; Lin and Chen, 2002; Liu et al., 2006) . However, the neural and hormonal mechanisms underlying the effects of GES on gastric sensory and motor functions are little known. The stomach receives dual innervations by vagal and splanchnic (sympathetic) nerves in both humans and animals, which play an important role in the regulation of gastric function. Previous studies using atropine and vagotomy in dogs have indicated that vagal afferent and/or efferent pathways are involved in the regulation of GES on gastric motility (Chen et al., 2003; Grundfest-Bronaltowski et al., 1990; Liu et al., 2004; Ouyang et al., 2003) . In rats, GES can activate vagal afferent fibers innervating the stomach (Peles et al., 2003) and modulate neuronal activity in the nucleus tractus solitarii, where vagal afferent fibers terminate (Qin et al., 2005) . A few recent studies suggest that the effects of GES with different parameters on gastric motility also involve the sympathetic nervous system. For example, GES significantly inhibits postprandial antral contractions. Guanethidine, an adrenergic blocker, can prevent this effect of GES, suggesting involvement of sympathetic pathways (Zhu and Chen, 2005) . Intravenous injections of propranolol or phentolamine is reported to abolish long-pulse GES-induced tachygastria and antral hypomotility via the alpha-and beta-adrenergic sympathetic pathways (Ouyang et al., 2005) . Thus, these studies provide evidence for a role of 
